George D. Yancopoulos
2021
Compensation breakdown
Non-Equity Incentive Plan | $4,030,584 |
---|---|
Salary | $1,767,800 |
Other | $599,980 |
Total | $6,398,364 |
Yancopoulos received $4M in non-equity incentive plan, accounting for 63% of the total pay in 2021.
Yancopoulos also received $1.8M in salary and $600K in other compensation.
Rankings
In 2021, George D. Yancopoulos' compensation ranked 1,987th out of 12,415 executives tracked by ExecPay. In other words, Yancopoulos earned more than 84.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,987 | 84th |
Manufacturing | 754 | 86th |
Chemicals And Allied Products | 292 | 88th |
Drugs | 251 | 88th |
Pharmaceutical Preparations | 162 | 90th |
Yancopoulos' colleagues
We found five more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2021.
2021
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
2021
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
2021
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2021
Joseph LaRosa
Regeneron Pharmaceuticals
General Counsel
2021
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
News
April 21, 2022
April 23, 2021
April 24, 2020
April 26, 2019